WSAAI 2022 59th Annual Scientific Session

February 6, 2022 to February 10, 2022

This year's meeting will cover novel diagnostics and therapeutics involved in severe asthma, the prevention of food allergies as well as cutting edge treatments for food allergies, address the skin as the largest immune organ and discuss other immunodeficiency and hypersensitivity disease.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunology and Western Society of Allergy, Asthma and Immunology (WSAAI). The American College of Allergy, Asthma & Immunology is accredited by the ACCME to provide continuing medical education for physicians.”

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 20 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commerical Support
This activity is supported by educational grants from CSL Behring, Grifols, Genentech, Optinose, AstraZeneca

Target Audience

Allergists and Allied Health Providers

Learning Objectives

Upon completion of this activity, participants should be able to:
- Recognize the different monoclonal antibody therapies for severe asthma and future agents in the drug pipeline
- Learn how gastroenterologists approach patients with mast cell disorders
- Recognize the current and potential roles of biologics to treat chronic rhinosinusitis
- Follow a world-expert in primary immunodeficiencies on how she approaches the diagnosis and treatment of PIDD

Additional information

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines an “ineligible company” as companies whose primary business is producing, marketing, re-selling, or distributing health care goods or services, used by or on patients. Examples of such organizations include:

Ambulatory procedure centers

  • Blood banks
  • Diagnostic labs that do not sell proprietary products
  • Electronic health records companies
  • Government or military agencies
  • Group medical practices
  • Health law firms
  • Health profession membership organizations
  • Hospitals or healthcare delivery systems
  • Infusion centers
  • Insurance or managed care companies
  • Nursing homes
  • Pharmacies that do not manufacture proprietary compounds
  • Publishing or education companies
  • Rehabilitation centers
  • Schools of medicine or health science universities
  • Software or game developers


The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All identified conflicts of interest have been mitigated

Course summary
Available credit: 
  • 20.00 AMA PRA Category 1 Credit™
  • 20.00 Attendance
  • 20.00 CBRN
Course opens: 
Course expires: 
Event starts: 
02/06/2022 - 3:00pm CST
Event ends: 
02/10/2022 - 6:00pm CST

Available Credit

  • 20.00 AMA PRA Category 1 Credit™
  • 20.00 Attendance
  • 20.00 CBRN
Please login or create an account to take this course.